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E-mail addresses: feiguin@icgeb.org (F. Feiguin), baPathological modiﬁcations in the highly conserved and ubiquitously expressed heterogeneous ribo-
nucleoprotein TDP-43 were recently associated to neurodegenerative diseases including amyotro-
phic lateral sclerosis (ALS), a late-onset disorder that affects predominantly motoneurons
[Neumann, M. et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyo-
trophic lateral sclerosis. Science 314, 130–133, Sreedharan, J. et al. (2008) TDP-43 mutations in famil-
ial and sporadic amyotrophic lateral sclerosis. Science 319, 1668–1672, Kabashi, E. et al. (2008)
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat.
Genet. 40, 572–574]. However, the function of TDP-43 in vivo is unknown and a possible direct role
in neurodegeneration remains speculative. Here, we report that ﬂies lacking Drosophila TDP-43
appeared externally normal but presented deﬁcient locomotive behaviors, reduced life span and
anatomical defects at the neuromuscular junctions. These phenotypes were rescued by expression
of the human protein in a restricted group of neurons including motoneurons. Our results demon-
strate the role of this protein in vivo and suggest an alternative explanation to ALS pathogenesis that
may be more due to the lack of TDP 43 function than to the toxicity of the aggregates.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
TDP-43 is a highly conserved and ubiquitously expressed nucle-
ar protein containing RNA binding motives and reported to be in-
volved in pre-mRNA splicing, transcription, mRNA stability, and
mRNA transport [4]. Recently, TDP-43 was identiﬁed as the main
protein component of the intracellular inclusions observed in af-
fected brain areas of patients suffering from Amyotrophic Lateral
Sclerosis (ALS), Frontotemporal Lobar Degeneration with ubiquiti-
nated inclusions (FTLD-U) [1,5,6] and Alzheimer disease (AD) [7–
9]. In the brain of these individuals TDP-43 appears depleted from
the cell nucleus and abnormally localized inside insoluble protein
aggregates throughout the cytoplasm. Moreover, missense muta-
tions in the C-terminal part of TDP-43 were identiﬁed in 2–5% of
sporadic and familial forms of ALS indicating that a tight correla-
tion between TDP-43 protein function and neurodegenerative dis-
eases may exist [2,3].
Despite the fact that the biochemical and structural properties
of TDP-43 were extensively studied, its physiological role in vivo
or the possible pathological mechanisms that may lead to neuronal
diseases were not determined [10]. Regarding this, considerable
attention has been given to the potential toxic effect of the TDP-chemical Societies. Published by E
ralle@icgeb.org (F.E. Baralle).43 protein aggregates observed in the cytoplasm. However it
should also be considered that in those neurons TDP-43 seems to
be absent from the nucleus. Therefore, it might be possible that
the defects observed in ALS patients reﬂect a loss of TDP-43 nuclear
function rather than a pure toxic effect of its aggregates.
We have previously shown that the Drosophila TDP-43 homo-
log was able to replace the splicing function of the human protein
in vitro and in tissue culture cells [11,12], for that reason we
decided to investigate the role of TDP-43 in vivo using Drosophila
melanogaster as the animal model.2. Material and methods
2.1. Generation of TBPH null alleles
TBPH loss-of-function alleles were generated by imprecise
mobilization of TBPHEY10530 transposon using D2–3 transposase.
Potential candidates were identiﬁed by the loss of w+ markers
and balanced to stock. Genomic DNA from 450 lines was used as
polymerase chain reaction templates. Primers ﬂanking the
EY10530 insertion were used for mapping (1R:19750253-
19750232; 2R:19750667-19750640; 1F:19746555-19746576;
3F:19747048-19747071; 4F:19748563-19748583; 5F:19749069-
19749089; 6F:19749727-19749746). TBPHD23 revealed a deletion
of 1616 bp with complete elimination of the P-element and breaklsevier B.V. All rights reserved.
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tion is from 19749289 to 19750093 including a fragment of
EY10530 imprecisely excised (1138 bp).2.2. Preparation of TBPH antibody
TBPH protein fragment from amino acids 1–268 GST conjugated
was expressed and puriﬁed from Escherichia coli over a GST-resin
following supplier protocols (Clontech #635610) and utilized to
immunize rabbits according to standard immunization protocols.2.3. Western blot analysis
Drosophila heads were squeezed in lysis buffer (10 mM Tris–
HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 10% Glycerol,
50 mM NaF, 5 mM DTT, 4 M Urea, and protease inhibitors (Roche
Diagnostic #11836170001). The proteins separated by 8% SDS–
PAGE, were transferred to nitrocellulose membranes (GE Health-
care #RPN303E) and probed with primary antibodies: TBPH
(1:3000) and tubulin (1:2000; Calbiochem #CP06). Secondary anti-
bodies: (HRP)-labeled anti-mouse or anti-rabbit antibodiesFig. 1. Depletion of Drosophila TBPH affects locomotive behavior and life span. (A) Sche
detects no endogenous protein in mutant ﬂy heads (upper panel) tubulin was a loadi
externally identical. (D) Life span reduction in TBPH mutant ﬂies can be rescued by ex
neurons. (E) Western blot analysis shows higher TBPH protein levels in ﬂy heads compare(1:10000) (Pierce #31460; #31430)) and developed using ECL
(#RPN2109; GE healthcare).
2.4. Immunohistochemistry
Larval body wall muscles were dissected in saline containing
0.1 mM Ca+2 and ﬁxed in ice-cold 4% paraformaldehyde for
20 min, washed in PBS/0.1% Tween 20, blocked with 5% Normal
Goat Serum (NGS Chemicon #S26-100 ML) 30 min. Primary Anti-
HRP antibody (Jackson Immunoresearch laboratories, #323-005-
021) (1:100) over night at 4 C. Secondary anti-rabbit antibody
conjugated with Alexa 488 (1:500) (Invitrogen #411008) or Phal-
loidin TRITC (1:500 dilution) for 2 h.
2.5. NMJ analysis
Wandering third instar larvae were processed as before and the
number of terminals branches and type 1b (big) and 1s (small)
boutons present in muscle 6/7 from abdominal segments 2 to 4
were quantiﬁed. To obtain the images from the synaptic terminals,
a 12–15 lmdeep Z-series containing the entire NMJ were collected
with a confocal laser-scanning microscope.matics of TBPH mutant alleles. (B) Western blot stained with anti-TBPH antibody,
ng control (bottom panel,). (C) Wild type controls and TBPH mutant ﬂies appear
pression of either drosophila or human TDP-43 transgene in D42-GAL4 expressing
d to torax or abdomen (upper panel). Tubulin was a loading control (bottom panel).
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Embryos from TBPHD23/CyoGFP, TBPHD142/CyoGFP and Oregon
R ﬂies were collected during two hours at 25. Homo or heterozy-
gous larvae, identiﬁed based on the absence or presence of GFP
expression, were selected between 26 and 28 h after egg laying
using a ﬂuorescent stereo microscope. Hatched ﬁrst instar wild
type, TBPH homozygous and heterozygous larvae were collected,
placed into new vials in batches of 25–30 larvae per vial, and
grown at 25C. Developmental viability was calculated as percent-
age of hatched ﬁrst instar larvae that survived to pupae and
adulthood.
2.7. Transgenic ﬂies and genetic rescue experiments
Endogenous TBPH and Human TDP-43 cDNAs were Flag tagged
and cloned in modiﬁed 10UAS vector (EcoRI-XbaI) to generate
transgenic ﬂies by standard embryo injections (Best Gene Inc.).
Insertion lines on the 3rd chromosome were combined with 2nd
chromosome TBPHD23 allele using second and third chromosome
compound balancer (ST). TBPHD23;UAShTDP-43/ST females wereTable 1
Developmental viability analysis of TBPH mutant ﬂies.
Genotypes 1st Instar larvae (28 h) N Pupa
TBPHD23/CyOGFP 1127 734 65%
TBPHD142/CyOGFP 1056 616 58%
TBPHD23/TBPHD23 930 591 64%
TBPHD142/TBPHD142 539 327 61%
OregonR 758 628 83%
Quantitative analysis of TBPH minus ﬂies from embryonic stages to adulthood indicat
Nevertheless, homozygous ﬂies present serious motility defects during eclosion and adu
Fig. 2. Endogenous TBPH protein is present in larval and adult brains. Anti-TBPH imm
localization of the endogenous protein. Squares (i0 , v0 , ix0) are higher magniﬁcations. Sign
phalloidin staining. Scale: 50 lm.crossed against TBPHD23;D42-GAL4/ST or TBPHD23;elav-GAL4/ST
males and the number of TBPHD23 homozygous ﬂies in the progeny
analyzed.
2.8. RNAi treatment in vivo and ﬂy stocks
The double strand RNAi against TBPH were obtained from VDRC
Vienna (ID38377 and ID38379) and target the genomic sequence
situated in the chromosomal position 19748365–19748665 that
corresponds to the TBPH amino acid sequences 81–180. These lines
were crossed against elav-GAL4 and 1407-GAL4 in wild type or
TBPHD23 heterozygous backgrounds. All crosses were done at
29C. All the stocks utilized here (elav-GAL4, 1407-GAL4, D42-
GAL4, D2-3-Sb/TM3 transposase and UAScd8GFP), were obtained
from Bloomington Drosophila Stock Center.
2.9. Larval movement
One hundred and twenty hours aged larvae were selected indi-
vidually, washed brieﬂy with distilled water to remove any
remaining food and carefully transferred to a LB agar plate underEclosed ﬂies Trapped ﬂies Motility defects (%)
586 52% 26 2% 0
446 42% 42 4% 0
197 21% 295 32% 100
86 16% 172 32% 100
543 72% 15 2% 0
es that this mutation induce little larval or pupal, -but not embryonic-, lethality.
lthood.
unostaining in wild type larval (i, v) and adult (ix) brains show the intracellular
al disappear in TBPHD23 homozygous brains (iii, vii and xi). ii, vi, x, iv, viii and xii are
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of peristaltic waves during the period of two minutes time were
counted. Around 30 larvae were counted for each genotype and
separate LB agar plate was used for each genotype.
2.10. Climbing assay
Newly eclosed males were transferred in batches of 30 to fresh
vials and aged for 3–4 days. They were transferred, without anes-
thesia, to a 15 ml conical tube, tapped to the bottom of the tube,
and their subsequent climbing activity quantiﬁed as the percent-
age of ﬂies that reach the top of the tube in 15 s.Fig. 3. Presynaptic TBPH function regulates ﬂies locomotion. (A) Expression of two dif
endogenous TBPH protein in adult heads (upper blot). First line shows TBPH transfected S
+) is for TBPHD23 heterozygous ﬂies. Tubulin was internal loading control (lower blot). (B
(left) and elav-GAL4>TBPH-RNAi (right), compared to wild type or GAL4 ﬂies expressing
ANOVA single factor. (C) TBPH homozygous or heterozygous alleles treated with elav-G
spontaneous walking and climbing activities (second, third and forth lanes of the righ
neuronal elav-GAL4 or the more restricted neuronal driver D42-GAL4. Similar rescue was
genotype, error bars indicate S.D.; P < 0.0001 calculated by ANOVA single factor. (D) W
TBPHD23/TBPHD23;elav-GAL4/UAShTDP-43 ﬂies were blotted using antibodies against TBP
Flagged hTDP-43 strains do not express endogenous TBPH. Tubulin was the loading con2.11. Walking assay
Newly eclosed males were transferred in batches of 15 to fresh
vials and aged for 3–4 days. Individual ﬂies were placed in the cen-
ter of 145 mm Petri dish marked with 1 cm square grid. Locomo-
tion was quantiﬁed as the number of grid line crossings during
30 s.
2.12. Life span
Adult ﬂies were collected during two days and transferred to
fresh tubes at a density of 20 per vial with a proportion of 10 maleferent TBPH RNAi insertions in neurons using 1407-GAL4 and elav-GAL4 reduced
2 cell extracts as a positive control. (+/+) states for wild type backgrounds while (/
) Climbing defects in TBPH RNAi treated ﬂies during time, 1407-GAL4 > TBPH-RNAi
UAS-LacZ. n = 100 ﬂies for genotype, error bars indicate S.D.; asterisk P < 0.0001 by
AL4 > TBPH RNAi (forth, ﬁfth and sixth lanes of the left graph), present impaired
t graph). These defects become suppressed by expressing hTDP-43 with the pan-
obtained with the endogenous TBPH protein (last three lanes). n = 50 ﬂies for each
estern blot analysis of rescued ﬂies. TBPHD23/TBPHD23;D42-GAL4/UAShTDP-43 and
H (upper blot) and against Flag to label ﬂagged hTDP-43 (middle blot). Observe that
trol (lower blot).
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ﬁed, temperature controlled incubator at 25 C and 60% humidity
on a 12-h light and 12 h dark cycle. Flies were fed with standard
cornmeal (2.9%), sugar (4.2%), yeast (6.3%) ﬂy food. Every third
day, ﬂies were transferred to new tubes containing fresh medium
and deaths were scored. Survival rate graph was plotted with per-
centage of survival ﬂies against days. Approximately 260 ﬂies were
tested per each genotype.
3. Results and discussion
3.1. Loss of Drosophila TDP-43 affects locomotive behaviors and life
span
To suppress the drosophila TDP-43 gene (TBPH-CG10327) we
generated chromosomal deletions from TBPHEY10530 (see Section
2). Two of these excised lines, TBPHD23 and TBPHD142 showed
small 1.6 and 0.8 kb deletions, respectively, that partially removedFig. 4. Morphological defects at neuromuscular synapsis in TBPH mutant ﬂies. (A) Conf
segment III) in wild type third instar larvae stained with anti-HRP antibodies, reveals the
boutons. (B) and (C) Similar staining and anatomical position for TBPHD23 and TBPHD142 h
of synaptic boutons. (D) TBPHD23 minus third instar larvae rescued by expressing UASh
with increased formation of synaptic boutons and axonal terminal branching. Magniﬁca
instar larvae. n = 20 for each genotype, error bars indicate S.D.; P < 0.0001 calculated by A
segments (n = 20 animals). (G) Analysis of small synaptic boutons (n = 20 animals). (H) Q
43/TBPH rescued third instar larva. n = 20 animals for each genotype, error bars indicatTBPH coding and regulatory regions (Fig. 1A). These deletions com-
pletely abolished endogenous protein expression and were there-
fore considered null alleles of TBPH (Fig. 1B). Homozygous
TBPHD23 or TBPHD142 ﬂies were viable after embryogenesis and
more than 60% of them arrived to pupal stages, with the majority
(80%) undergoing metamorphosis. Nevertheless, a high percent
of TBPH mutant animals were unable to eclose and remained
trapped inside their pupal cages (Table 1). Homozygous ﬂies that
instead managed to get rid of the external cuticle were morpholog-
ically identical to wild type controls (Fig. 1C), however, they pre-
sented dramatic locomotive defects with spastic, uncoordinated,
movements, incapacity to ﬂy or walk normally and reduced life
span (Fig. 1D and Supplementary Movies S1 and S2).
To determine the place of TBPH function, we explored its
endogenous distribution and intracellular localization. TBPH pro-
tein was present at higher concentrations in head tissues com-
pared with thorax or abdomen in adult ﬂies (Fig. 1E). Similarly,
our anti-TBPH antibody could detect the endogenous protein inocal images of motoneurons presynaptic terminals at muscles 6 and 7 (abdominal
branching pattern and the presence of big (arrowhead) and small (arrow) synaptic
omozygous larvae respectively, show reduced axonal branching pattern and number
TDP-43 in motoneurons with D42-GAL4 shows recovery of presynaptic complexity
tion 63. (E) Number of peristaltic waves observed during 2 minutes in 120 h third
NOVA. (F) Quantiﬁcation of big synaptic boutons present in consecutives abdominal
uantiﬁcation of presynaptic terminals branches in wild type, TBPH minus and hTDP-
e S.D.; P < 0.0001 calculated by ANOVA single factor. Scale: 10 lm.
Fig. 5. Possible mechanism of TDP-43 mediated neurological defects in ALS. TDP-43
is a nuclear protein that in wild type situation shuttles to the cytoplasm. In ALS
brains instead, it becomes abnormally aggregated in the cytoplasm and depleted
from the cell nucleus suggesting that these modiﬁcations may be related to the
neurological problems observed in these patients. We found that depletion of
Drosophila TDP-43 was sufﬁcient to generate atrophic presynaptic terminals and to
induce locomotive defects in vivo. Since the human TDP-43 protein was able to
assume the role of the endogenous gene in ﬂies, we hypothesize that nuclear loss of
TDP-43 function may be related to the locomotion problems observed in the
disease. This view provides a new interpretation of the pathological mechanisms in
ALS and predicts similar defects at neuromuscular junctions in affected patients.
F. Feiguin et al. / FEBS Letters 583 (2009) 1586–1592 1591neuronal cells during larval development and adulthood (Fig. 2).
TBPH staining showed very well deﬁned spherical structures that
may correspond to the cell nucleus inside neuronal cell bodies
present in optic lobes (Fig. 2i and ii) midbrain areas and ventral
ganglia of larval (Fig. 2v and vi) and adult brains (Fig. 2ix and x).
Identical immunostaining performed in TBPH minus tissues did
not detected any particular signal conﬁrming the speciﬁcity of
the observations described above (Fig. 2iii, iv, vii, viii, xi and xii).
These experiments demonstrate that TBPH is highly expressed in
neuronal tissues from developmental stages to adulthood and sug-
gest that its loss of function may induce locomotive deﬁcits of neu-
rological origin.
3.2. TDP-43 function in neurons regulates ﬂies locomotion
To test this hypothesis, we decided to suppress TBPH expression
by RNA interference (RNAi) exclusively in neural tissues [13].
Expression of TBPH RNAi using two different pan-neuronal drivers
elav-GAL4 and 1407-GAL4 [14], consistently reduced endogenous
TBPH protein levels in Drosophila heads and induced locomotive
defects in climbing assays (Fig. 3A and B). More convincingly, we
observed that these phenotypes became enhanced if similar RNAi
treatments were applied to TBPH heterozygous ﬂies (see elav > R-
NAi3v; TBPHD23/+ in Fig. 3C and Supplementary Movie S3), indicat-
ing that suppression of TBPH activity in post mitotic neurons was
the presynaptic activity of sufﬁcient to induce locomotive defects
in vivo. To conﬁrm these results we decided to rescue TBPH minus
phenotypes by reintroducing the deleted gene. In addition, we
decided to test whether the human protein (hTDP-43) was able
to replace the endogenous protein in vivo. For these experiments
we generated transgenic ﬂies containing ﬂag tagged TBPH and
hTDP-43 cDNAs and targeted their expression in TBPHminus back-
grounds using the GAL4/UAS system (Fig. 3D). Strikingly, we found
that the expression of hTDP-43 by the neuronal post mitotic driver
elav-GAL4 managed to rescue the motility defects observed in
TBPH homozygous ﬂies to a situation similar to wild type
(Fig. 3C, and Supplementary Movie S4). Moreover, we found that
expression of hTDP-43 in a more restricted population of neurons
that include motoneurons by D42-GAL4 [15], was sufﬁcient to res-
cue TBPH null phenotypes. In fact, these ﬂies recovered their loco-
motive capacities (Fig. 3C, and Supplementary Movie S5) and
incremented their life span (Fig. 1D) demonstrating that hTDP-43
function is evolutionary conserved and sufﬁcient in a limited sub-
population of neurons to restore these traits. However, the partial
recovery of the life span observed in these D42-GAL4 expressing
ﬂies indicates that TDP-43 may also be required in other types of
neurons or different tissues.
3.3. TDP-43 regulates the formation of motoneurons presynaptic
terminals at NMJ
To gain insight into the mechanisms behind these motility de-
fects, we decided to analyze the morphology of motoneurons pre-
synaptic terminals at neuromuscular junctions (NMJ) in TBPH
minus ﬂies. To label these structures we used anti horseradish per-
oxidase antibodies (HRP) that label neuronal membranes [16] and
quantiﬁed the synaptic pattern of motoneuron axons that inner-
vate muscles 6 and 7 in three different larval abdominal segments
(AII, AIII, AIV). These structures present two types of synaptic bou-
tons that can be easily distinguish by their size in 1b (big) and 1s
(small) (Fig. 4A) [17]. We observed that in TBPH minus larvae,
the complexity of the presynaptic terminals became dramatically
affected as reﬂected by the reduced number of axonal branches
and synaptic boutons present inside the muscles (Fig. 4B and C,
F–H). In addition, we found that these anatomical defects together
with the functional problems in larval motility could be rescued bythe expression of hTDP-43 under D42-Gal4 (Fig. 4D and E) indicat-
ing that the morphological modiﬁcations observed at the synaptic
terminals are the basis of these behavioral problems and TBPH/
hTDP-43 function is required to form and maintain these
structures.
Thus, our results demonstrate that the activity of TDP-43 in
neurons is necessary to regulate locomotive behaviors in vivo
and indicates that the neurological problems observed in ALS pa-
tients may not be restricted to the formation of insoluble protein
fragments of aggregated TDP-43 within the cytosol but also to
the loss of TDP-43 function in the nucleus (see model in Fig. 5).
In view that TDP-43 was characterized as RNA binding protein
of the heterogeneous nuclear ribonucleoproteins (hnRNP) family
with splicing inhibitory capacity [18], it may well be that TDP-43
induce motoneurons defects by affecting spliceosomes activity
and/or mRNA transport and localization. Similarly, multiple defects
in mRNA processing associated with locomotive deﬁciencies were
recently described for the survival motor neuron protein (SMN)
[19], giving a major support to the idea that defects in the mRNA
metabolism may play a signiﬁcant role in motoneuron degenera-
tion. In conclusion our data demonstrate an evolutionary con-
served function of TDP-43 in regulating synaptic terminals and
locomotive behaviors and provide a new model to understand
the mechanisms that lead to TDP-43 mediated neurological dis-
eases in vivo.
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